CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
Published on:
Daniel Some, Russell Burge
BioPharm International, BioPharm International-10-15-2015, Volume 2015 eBook, Issue 2
This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
BioPharm International
eBooks Volume 28, Issue 14
Assessing a drug candidate’s suitability during preformulation is essential to minimize the risk of costly downstream failure. Stability is a defining feature of biotherapeutic performance; measuring formulation stability during early-phase screening allows developers to make robust predictions of suitability for further development. Read this article and other articles in
Advertisement
BioPharm International
's 2015
eBook.
